Evidence map›Paper›PMID 24760894›Full record

ArticleJournal of virology2014

Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.

Ahmed A Quadeer, Raymond H Y Louie, Karthik Shekhar, Arup K Chakraborty, I-Ming Hsing, Matthew R McKay

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ahmed A QuadeerDepartment of Electronic and Computer Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong.
Raymond H Y LouieDepartment of Electronic and Computer Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong.
Karthik ShekharDepartment of Chemical Engineering, MIT, Cambridge, Massachusetts, USA Ragon Institute of Massachusetts General Hospital, MIT and Harvard, Boston, Massachusetts, USA.
Arup K ChakrabortyDepartment of Chemical Engineering, MIT, Cambridge, Massachusetts, USA Ragon Institute of Massachusetts General Hospital, MIT and Harvard, Boston, Massachusetts, USA Department of Physics, MIT, Cambridge, Massachusetts, USA Department of Chemistry, MIT, Cambridge, Massachusetts, USA Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA Institute for Medical Engineering and Science, MIT, Cambridge, Massachusetts, USA Institute for Advanced Study, HKUST, Clear Water Bay, Kowloon, Hong Kong.
I-Ming HsingDepartment of Chemical and Biomolecular Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong Division of Biomedical Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong.
Matthew R McKayDepartment of Electronic and Computer Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong Division of Biomedical Engineering, HKUST, Clear Water Bay, Kowloon, Hong Kong eemckay@ust.hk.
Hong Kong University of Science and Technology · HKRagon Institute of MGH, MIT and Harvard · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledChronic hepatitis C virus (HCV) infection is one of the leading causes of liver failure and liver cancer, affecting around 3% of the world's population. The extreme sequence variability of the virus resulting from error-prone replication has thwarted the discovery of a universal prophylactic vaccine. It is known that vigorous and multispecific cellular immune responses, involving both helper CD4(+) and cytotoxic CD8(+) T cells, are associated with the spontaneous clearance of acute HCV infection. Escape mutations in viral epitopes can, however, abrogate protective T-cell responses, leading to viral persistence and associated pathologies. Despite the propensity of the virus to mutate, there might still exist substitutions that incur a fitness cost. In this paper, we identify groups of coevolving residues within HCV nonstructural protein 3 (NS3) by analyzing diverse sequences of this protein using ideas from random matrix theory and associated methods. Our analyses indicate that one of these groups comprises a large percentage of residues for which HCV appears to resist multiple simultaneous substitutions. Targeting multiple residues in this group through vaccine-induced immune responses should either lead to viral recognition or elicit escape substitutions that compromise viral fitness. Our predictions are supported by published clinical data, which suggested that immune genotypes associated with spontaneous clearance of HCV preferentially recognized and targeted this vulnerable group of residues. Moreover, mapping the sites of this group onto the available protein structure provided insight into its functional significance. An epitope-based immunogen is proposed as an alternative to the NS3 epitopes in the peptide-based vaccine IC41. IMPORTANCE: Despite much experimental work on HCV, a thorough statistical study of the HCV sequences for the purpose of immunogen design was missing in the literature. Such a study is vital to identify epistatic couplings among residues that can provide useful insights for designing a potent vaccine. In this work, ideas from random matrix theory were applied to characterize the statistics of substitutions within the diverse publicly available sequences of the genotype 1a HCV NS3 protein, leading to a group of sites for which HCV appears to resist simultaneous substitutions possibly due to deleterious effect on viral fitness. Our analysis leads to completely novel immunogen designs for HCV. In addition, the NS3 epitopes used in the recently proposed peptide-based vaccine IC41 were analyzed in the context of our framework. Our analysis predicts that alternative NS3 epitopes may be worth exploring as they might be more efficacious.

Indexed as

Amino Acid SubstitutionData Interpretation, StatisticalDEAD-box RNA HelicasesGenotypeHepacivirusHepatitis CHumansImmunity, CellularImmunodominant EpitopesMutationNucleoside-TriphosphataseProtein ConformationSerine EndopeptidasesViral Nonstructural ProteinsViral ProteasesDEAD-box RNA HelicasesImmunodominant EpitopesNS3 protein, hepatitis C virusNucleoside-TriphosphataseSerine EndopeptidasesViral Nonstructural ProteinsViral Proteases

Identifiers

PMID24760894
PMCPMC4054436
OpenAlexW2017052897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.